Intrinsic value of ProFunds Biotechnology UltraSector Fund Investor Class (BIPIX)
Live fair value data for ProFunds Biotechnology UltraSector Fund Investor Class (BIPIX) is currently unavailable. Please check again shortly.
Current Price: $180.00
Valuation: Overvalued
Confidence: 5.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is ProFunds Biotechnology UltraSector Fund Investor Class (BIPIX) undervalued or overvalued?
Based on the current model output, ProFunds Biotechnology UltraSector Fund Investor Class appears to be overvalued with a downside of 12.00%.
Fair value vs market price — ProFunds Biotechnology UltraSector Fund Investor Class (BIPIX)
Unlock premium access to view the live fair value comparison against current market price for BIPIX.
Frequently Asked Questions - BIPIX
How is BIPIX intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for BIPIX.
Is BIPIX undervalued or overvalued right now?
BIPIX is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for BIPIX: open their intrinsic value pages.
- BBarrick Mining Corporation
- CRAAXColumbia Adaptive Risk Allocation Fund A
- GVCAXThe Gabelli Value 25 Fund Inc. Class AAA
- EMEAXAshmore Emerging Markets Equity Fund - Class A
- SDVGXSit Dividend Growth Fund Class I
- EMFIXAshmore Emerging Markets Equity Fund - Institutional Class
- RYVFXRoyce Small-Cap Value Fund - Service Class
- SDVSXSit Dividend Growth Fund Class S